CPhI Festival of Pharma
CPhI: cell and gene therapy capacity shortages on the horizon
CPhI’s Annual Report 2020 predicts impending cell and gene capacity shortages for the US market, and possible mAb production growth in China.
CPhI Festival of Pharma
CPhI’s Annual Report 2020 predicts impending cell and gene capacity shortages for the US market, and possible mAb production growth in China.
To accelerate Covid-19 vaccine development, as well as upscale domestic manufacturing capabilities, the German government has announced a €750m (US$890m) fund to support the vaccine programs of three German developers, BioNTech, CureVac and IDT Biologika.